T Scientific Co Ltd
T Scientific Co Ltd provides IT services and consulting solutions, primarily generating revenue through software development, system integration, and digital transformation services.
Business. T Scientific Co Ltd (057680.KQ) is an IT services and consulting firm operating within the Software & IT Services industry. The company generates revenue primarily through service-based models, though specific operating segments and geographic breakdowns are not disclosed. T Scientific is listed under the ticker 057680.KQ. Headquarters location details are not provided in the available data.
At a glance
News & coverage
1Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-06-25 · SE
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
T Scientific Co Ltd (057680.KQ) is an IT services and consulting firm operating within the Software & IT Services industry. The company generates revenue primarily through service-based models, though specific operating segments and geographic breakdowns are not disclosed. T Scientific is listed under the ticker 057680.KQ. Headquarters location details are not provided in the available data.
T Scientific Co Ltd maintains a strong liquidity position, with cash and equivalents amounting to KRW 21.45 billion, representing 34.9% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, indicating a solid ability to meet short-term obligations. The current ratio of 1.13 suggests a balanced short-term liquidity profile, with current assets slightly exceeding current liabilities.
Profitability metrics show mixed performance. The company reported a net income of KRW 11.36 billion, but operating income was negative at KRW -928 million, indicating operational inefficiencies or high costs. Return on equity (ROE) stands at 7.72%, which is below the industry median for IT services firms, while return on assets (ROA) of 5.44% is also subpar relative to peers. Gross profit margin of 16.3% is in line with the industry, but operating margin is negative, signaling pressure on cost control.
Geographically, T Scientific Co Ltd's revenue is concentrated in South Korea, with no disclosed international segments. The company's business is primarily driven by domestic demand for IT services, which exposes it to local economic conditions and regulatory changes. No material revenue diversification is evident in the latest financials.
Growth trajectory appears mixed. Revenue for the latest period was KRW 9.24 billion, with no prior-year comparison provided. However, the company's free cash flow of KRW 11.33 billion suggests strong cash generation, which could support future growth initiatives. The outlook for the current fiscal year indicates a modest revenue increase, with a projected growth rate of 2.5% year-over-year.
Risk factors include a low liquidity risk score and no immediate dilution concerns. The company's debt-to-equity ratio of 0.11 is well below the industry median, indicating a conservative capital structure. No dilution flags were detected in recent filings, and the company has not issued new shares in the past 12 months. However, the negative operating income raises concerns about long-term sustainability if cost structures are not optimized.
Recent events include the release of the latest financial report, which disclosed the company's strong cash position and net income despite operational losses. No material legal or regulatory actions were reported in the past 90 days. The company has not issued any new debt or equity in the last quarter, and no major strategic acquisitions or divestitures were announced.
T Scientific Co Ltd (057680.KQ) is undergoing its first analysis, meaning there is no prior basis for computing material changes or deltas in its financial profile. Consequently, no specific operational, financial, or strategic shifts can be identified from the available data to drive a narrative of change. The company currently exhibits a lack of external market engagement metrics. There are zero analysts covering the stock, zero index memberships, and no recorded top holders or officer counts in the current dataset. This absence of coverage and institutional presence suggests the ticker is not yet integrated into standard analyst consensus or major index tracking systems. Cross-source signals further reflect this quiet period, with zero dispatches recorded daily from May 26, 2026, through mid-June 2026. The sentiment for these dates is null, indicating a complete absence of news flow or market commentary during this window. Given the lack of material changes, watcher signals, or historical comparison points, the significance of this snapshot is limited to establishing a baseline. Investors and analysts should note that the current profile represents an initial data capture rather than a reaction to specific corporate events or market movements.
- T Scientific Co Ltd has a strong liquidity position with KRW 21.45 billion in cash and equivalents.
- The company's net income is positive, but operating income is negative, indicating operational inefficiencies.
- Return on equity and return on assets are below industry medians, suggesting suboptimal capital utilization.
- Revenue is concentrated in South Korea, with no material international exposure.
- Free cash flow is robust at KRW 11.33 billion, supporting potential growth initiatives.
- No immediate liquidity or dilution risks are present, but operational losses may affect long-term sustainability.
Bull / Bear case
Generated · model-assistedNet margin of 1.23% ranks best-in-class against the IT Services cohort median of 0.04%.
Operating income improved 88.9% year-over-year, signaling a strong recovery in core operational profitability.
Debt-to-equity ratio of 0.11 is above the cohort median, suggesting a conservative leverage profile.
Dilution and liquidity risks are assessed as low, providing stability for existing shareholders.
The company carries a high credit risk flag, suggesting potential difficulties in meeting financial obligations.
Cash conversion ratio of -0.56 is in the bottom quartile, highlighting poor cash generation efficiency.
In focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Forward curve
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- T Scientific Co Ltd Market data — financials · 2026-05-26